Paul Davies

This variability makes Parkinson’s particularly challenging to diagnose, treat and manage. In West Yorkshire, the integrated care board is responsible for planning and delivering care for people with Parkinson’s. In 2023-24, spending on hospital admissions for Parkinson’s patients in our area rose by nearly 5%, with each admission costing more than £6,000. These figures underscore the urgent need for a more proactive, community-based approach to care—one that prevents hospitalisations and supports people to live well at home. Today I want to highlight five critical areas in which we must act to improve care for people living with Parkinson’s: workforce shortages, support from diagnosis, timely medication, prescription charges, and access to innovation. There is a severe shortage of neurologists and Parkinson’s specialists in the UK, and neurology services are meeting the 18-week referral target only about half of the time. The UK ranks near the bottom in Europe for the number of neurologists per capita. This shortage leads to delayed diagnoses, missed treatment windows, and a lack of access to essential multidisciplinary care. Only 44% of patients in England have access to an occupational therapist, 62% to a physiotherapist, and just 40% to a speech and language therapist. These professionals are not luxuries; they are essential to managing the condition and maintaining quality of life. Investing in this workforce is not only clinically necessary, but financially prudent.